{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T17:33:59Z","timestamp":1774114439935,"version":"3.50.1"},"reference-count":29,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2025,7,25]]},"DOI":"10.1253\/circj.cj-24-0989","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T18:07:53Z","timestamp":1747246073000},"page":"1153-1161","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of Extended Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting in Patients With High Inflammatory Risk"],"prefix":"10.1253","volume":"89","author":[{"given":"Woo Jin","family":"Jang","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Hong","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Jeonbuk National University Hospital, Jeonbuk National University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo-Yong","family":"Hahn","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Hyuk","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon-Cheol","family":"Gwon","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiick","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wook Sung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Seop","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Bin","family":"Song","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ridker PM. Clinician\u2019s guide to reducing inflammation to reduce atherothrombotic risk: JACC review topic of the week. <i>J Am Coll Cardiol<\/i> 2018; 72: 3320\u20133331.","DOI":"10.1016\/j.jacc.2018.06.082"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, et al. Prognostic significance of the Centers for Disease Control\/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. <i>Circulation<\/i> 2007; 115: 1528\u20131536.","DOI":"10.1161\/CIRCULATIONAHA.106.649939"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tunon J, Back M, Badimon L, Bochaton-Piallat ML, Cariou B, Daemen MJ, et al. Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice. <i>Eur J Prev Cardiol<\/i> 2018; 25: 948\u2013955.","DOI":"10.1177\/2047487318773384"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines: An update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. <i>Circulation<\/i> 2016; 134: e123\u2013e155.","DOI":"10.1161\/CIR.0000000000000404"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). <i>Eur Heart J<\/i> 2018; 39: 213\u2013260.","DOI":"10.1093\/eurheartj\/ehx638"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Verma S, Goodman SG, Mehta SR, Latter DA, Ruel M, Gupta M, et al. Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials. <i>BMC Surg<\/i> 2015; 15: 112.","DOI":"10.1186\/s12893-015-0096-z"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC\/EACTS guidelines on myocardial revascularization. <i>Eur Heart J<\/i> 2019; 40: 87\u2013165.","DOI":"10.1093\/eurheartj\/ehy855"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sousa-Uva M, Head SJ, Milojevic M, Collet JP, Landoni G, Castella M, et al. 2017 EACTS guidelines on perioperative medication in adult cardiac surgery. <i>Eur J Cardiothorac Surg<\/i> 2018; 53: 5\u201333.","DOI":"10.1093\/ejcts\/ezx314"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. <i>N Engl J Med<\/i> 2005; 352: 1685\u20131695.","DOI":"10.1056\/NEJMra043430"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Libby P, Ridker PM, Hansson GK, Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: From pathophysiology to practice. <i>J Am Coll Cardiol<\/i> 2009; 54: 2129\u20132138.","DOI":"10.1016\/j.jacc.2009.09.009"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Balciunas M, Bagdonaite L, Samalavicius R, Griskevicius L, Vuylsteke A. Pre-operative high sensitive C-reactive protein predicts cardiovascular events after coronary artery bypass grafting surgery: A prospective observational study. <i>Ann Card Anaesth<\/i> 2009; 12: 127\u2013132.","DOI":"10.4103\/0971-9784.53442"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zhang YX, Cliff WJ, Schoefl GI, Higgins G. Coronary C-reactive protein distribution: Its relation to development of atherosclerosis. <i>Atherosclerosis<\/i> 1999; 145: 375\u2013379.","DOI":"10.1016\/S0021-9150(99)00105-7"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Alonso-Martinez JL, Llorente-Diez B, Echegaray-Agara M, Olaz-Preciado F, Urbieta-Echezarreta M, Gonzalez-Arencibia C. C-reactive protein as a predictor of improvement and readmission in heart failure. <i>Eur J Heart Fail<\/i> 2002; 4: 331\u2013336.","DOI":"10.1016\/S1388-9842(02)00021-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bohula EA, Giugliano RP, Cannon CP, Zhou J, Murphy SA, White JA, et al. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT. <i>Circulation<\/i> 2015; 132: 1224\u20131233.","DOI":"10.1161\/CIRCULATIONAHA.115.018381"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. <i>N Engl J Med<\/i> 2017; 377: 1119\u20131131.","DOI":"10.1056\/NEJMoa1707914"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yamamoto K, Morimoto T, Natsuaki M, Shiomi H, Ozasa N, Sakamoto H, et al. Polypharmacy and bleeding outcomes after percutaneous coronary intervention. <i>Circ J<\/i> 2024; 88: 888\u2013899.","DOI":"10.1253\/circj.CJ-23-0558"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yamamoto K, Shiomi H, Morimoto T, Miyazawa A, Watanabe H, Nakamura S, et al. Dual antiplatelet therapy duration after multivessel optimal intravascular ultrasound-guided percutaneous coronary intervention. <i>Circ J<\/i> 2023; 87: 1661\u20131671.","DOI":"10.1253\/circj.CJ-23-0141"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Fujiyoshi A, Kohsaka S, Hata J, Hara M, Kai H, Masuda D, et al. JCS 2023 guideline on the primary prevention of coronary artery disease. <i>Circ J<\/i> 2024; 88: 763\u2013842.","DOI":"10.1253\/circj.CJ-23-0285"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Muller KA, Chatterjee M, Rath D, Geisler T. Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD. <i>Thromb Haemost<\/i> 2015; 114: 498\u2013518.","DOI":"10.1160\/TH14-11-0947"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Mangano DT, Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. <i>N Engl J Med<\/i> 2002; 347: 1309\u20131317.","DOI":"10.1056\/NEJMoa020798"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ebrahimi R, Bakaeen FG, Uberoi A, Ardehali A, Baltz JH, Hattler B, et al. Effect of clopidogrel use post coronary artery bypass surgery on graft patency. <i>Ann Thorac Surg<\/i> 2014; 97: 15\u201321.","DOI":"10.1016\/j.athoracsur.2013.08.058"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Rafiq S, Johansson PI, Kofoed KF, Lund JT, Olsen PS, Bentsen S, et al. Thrombelastographic hypercoagulability and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): A randomized controlled trial. <i>Platelets<\/i> 2017; 28: 786\u2013793.","DOI":"10.1080\/09537104.2017.1280147"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Carrero JJ, Andersson Franko M, Obergfell A, Gabrielsen A, Jernberg T. hsCRP level and the risk of death or recurrent cardiovascular events in patients with myocardial infarction: A healthcare-based study. <i>J Am Heart Assoc<\/i> 2019; 8: e012638.","DOI":"10.1161\/JAHA.119.012638"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. <i>Eur J Cardiothorac Surg<\/i> 2018; 53: 34\u201378.","DOI":"10.1016\/j.rec.2017.11.020"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. S\u00f8rensen R, Abildstr\u00f8m SZ, Hansen PR, Hvelplund A, Andersson C, Charlot M, et al. Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction. <i>J Am Coll Cardiol<\/i> 2011; 57: 1202\u20131209.","DOI":"10.1016\/j.jacc.2010.09.069"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kleveland O, Kunszt G, Bratlie M, Ueland T, Broch K, Holte E, et al. Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: A double-blind, randomized, placebo-controlled phase 2 trial. <i>Eur Heart J<\/i> 2016; 37: 2406\u20132413.","DOI":"10.1093\/eurheartj\/ehw171"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Martinez GJ, Celermajer DS, Patel S. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation. <i>Atherosclerosis<\/i> 2018; 269: 262\u2013271.","DOI":"10.1016\/j.atherosclerosis.2017.12.027"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Bj\u00f6rklund E, Nielsen SJ, Hansson EC, Karlsson M, Wallinder A, Martinsson A, et al. Secondary prevention medications after coronary artery bypass grafting and long-term survival: A population-based longitudinal study from the SWEDEHEART registry. <i>Eur Heart J<\/i> 2020; 41: 1653\u20131661.","DOI":"10.1093\/eurheartj\/ehz714"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Chikwe J, Lee T, Itagaki S, Adams DH, Egorova NN. Long-term outcomes after off-pump versus on-pump coronary artery bypass grafting by experienced surgeons. <i>J Am Coll Cardiol<\/i> 2018; 72: 1478\u20131486.","DOI":"10.1016\/j.jacc.2018.07.029"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/8\/89_CJ-24-0989\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T03:39:14Z","timestamp":1753501154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/8\/89_CJ-24-0989\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-24-0989","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"article-number":"CJ-24-0989"}}